Manning & Napier Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Manning & Napier Advisors's PFE Position: Q2 2026 in Review
Manning & Napier Advisors increased its Pfizer (PFE) stake by 2.2% in Q2 2026, buying an estimated $44.2K and bringing the position to 79,351 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #222.
Manning & Napier Advisors first reported a position in PFE in Q2 2013 and has held it in 21 quarters since. The position peaked at $32.1M in Q3 2013. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Manning & Napier Advisors held 79,351 shares of Pfizer worth $1.93M as of Q2 2026.
- Manning & Napier Advisors bought 1,688 Pfizer shares in Q2 2026, an estimated $44.2K.
- Pfizer made up 0.02% of Manning & Napier Advisors's portfolio in Q2 2026, its #222 holding.
- Manning & Napier Advisors first reported a position in Pfizer in Q2 2013 and has held it in 21 quarters since.
- Manning & Napier Advisors's Pfizer position peaked at $32.1M in Q3 2013.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.